XML 19 R6.htm IDEA: XBRL DOCUMENT v3.22.2
CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY (unaudited) - USD ($)
$ in Millions
Total
Share capital
Other reserves
Fair value adjustments on equity securities
Actuarial gains/(losses) from defined benefit plans
Cumulative currency translation effects
Total value adjustments
 [1]
Beginning balance at Dec. 31, 2020 $ 18,822 $ 20 $ 18,899 $ (32) $ (109) $ 44 $ (97)
Net income 235   235        
Other comprehensive income (3)     0 15 (18) (3)
Total comprehensive income 232   235 0 15 (18) (3)
Dividends (53)   (53)        
Equity-based compensation 47   47        
Other movements [2] 16   4   12   12
Total other movements 10   (2)   12   12
Ending balance at Jun. 30, 2021 19,064 20 19,132 (32) (82) 26 (88)
Beginning balance at Dec. 31, 2021 19,256 20 19,356 (32) (74) (14) (120)
Net income 316   316        
Other comprehensive income 56     1 120 (65) 56
Total comprehensive income 372   316 1 120 (65) 56
Dividends (102)   (102)        
Equity-based compensation 4   4        
Other movements [2] 11   11       0
Total other movements (87)   (87)   0   0
Ending balance at Jun. 30, 2022 $ 19,541 $ 20 $ 19,585 $ (31) $ 46 $ (79) $ (64)
[1] "Total value adjustments" are presented net of the corresponding tax effects.
[2] Activity includes hyperinflationary accounting. The prior year period includes an adjustment to actuarial gains to recognize plan assets related to the separation of a pension plan in the spin-off from Novartis but which were not previously recorded.